Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CFAP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100505715 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TROVE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF235 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1462 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723704 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928135 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NYAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on